Related Experiment Video
Updated: Aug 30, 2026
07:35
Evaluation of Colorectal Cancer Risk and Prevalence by Stool DNA Integrity Detection
Published on: June 8, 2020
Is it acceptable to approach colorectal cancer patients at diagnosis to discuss genetic testing? A pilot study
M Porteous1, M Dunckley, S Appleton
1Department of Clinical Genetics, Molecular Medicine Centre, Western General Hospital, Crewe Road South, Edinburgh EH4 2XU, UK. mary.porteous@ed.ac.uk
British Journal of Cancer
|October 17, 2003
Abstract:
In this pilot study, the acceptability of approaching 111 newly diagnosed colorectal cancer patients with the offer of genetic testing for hereditary nonpolyposis colorectal cancer (HNPCC) was assessed. A total of 78% of participants found it highly acceptable to have the information about HNPCC brought to their attention at that time.
